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A highly neuropathogenic retrovirus, NT40, was generated by serially passaging an infectious molecular clone of Friend
murine leukemia virus, FB29, through F344 Fisher rats. NT40 induced severe neurological signs such as reflex abnormalities
and ataxia within 4– 6 weeks following neonatal inoculation. FB29 led to only very mild neurological dysfunctions with
longer incubation periods. Pathological alterations were characterized by mild (FB29) to extensive (NT40) noninflammatory
spongiform degeneration, mainly of brain-stem areas. Infectious center assays revealed that viral titers in brain tissues of
NT40-infected rats were 100-fold higher than those of FB29-infected animals. Employing immunohistochemistry, in situ
hybridization, and flow cytometry, NT40 was found to infect many endothelial cells of brain blood vessels and microglia,
whereas FB29 infected only microglia and those to a lower extent. However, when isolated from adult diseased rats,
microglial cells turned out in both cases to be nonproductively infected with either FB29 or NT40. Of peripheral organs,
we found enhanced levels of NT40 in peritoneal macrophages but not in spleen, thymus, or serum when compared to FB29.
Altogether these data suggest that an expanded cellular tropism within the CNS and elevated viral titers in macrophages
and microglia correlated with enhancement of neuropathogenicity. q 1995 Academic Press, Inc.
Retroviral infection of the central nervous system neuropathogenic MuLV, i.e., whether an enhanced mac-
rophage/microgliatropism would evolve after serial in(CNS) may result in neurodegenerative disease. A coin-
ciding observation in lentivirus infections, such as human vivo passaging of MuLV and whether this would correlate
with enhanced neuropathogenicity.immunodeficiency virus (1, 2, reviewed in 3), simian im-
munodeficiency virus (4, 5), and feline immunodeficiency A new variant of MuLV, NT40, was isolated after serial
passage of a molecular clone of Friend MuLV, FB29 (16),virus (6), as well as in murine leukemia virus (MuLV)
models, (7– 12) is that degenerating neurons do not ap- through F344 Fisher rats. The inocula were prepared
from spleen and brain tissues of neonatally infected do-pear to be infected. Current hypotheses on the pathogen-
esis of retroviral neurodegeneration are therefore fo- nor rats not older than 3 weeks at the time of sacrifice.
After the third passage, brain material was used to infectcused on indirectly mediated mechanisms of neuronal
injury, probably initiated by retrovirus-infected cells. NIH3T3 cells. Virus obtained from the supernatant was
cloned by limiting dilutions on Fisher rat embryo cells.Within the CNS parenchyma, macrophages and/or mi-
croglia are major targets for lentiviruses and MuLV. In Intraperitoneal (ip) inoculation of neonatal Fisher rats
with clone NT40 induced severe reflex abnormalities ofprimates, emergence of macrophage/microgliatropic vi-
rus variants from nonmacrophagetropic virus strains ap- fore- and hindlimbs and subsequent ataxia within 4– 6
weeks postinfection (pi). Later in disease some NT40-pears to be crucial for the development of neurodegener-
ation and has been reported to occur after both in vivo infected animals developed priapism. In contrast, neona-
tal inoculation (ip) with the parental clone FB29 led topropagation (13, 14) and sequential intracerebral pas-
sages (15). Here, we addressed a similar question for very mild reflex abnormalties of hind- and occasionally
forelimbs within 8– 12 weeks pi. Clinical evaluations in-
volved examinations of the movements of rats in the1 To whom reprint requests should be addressed at Institut fu¨r Virolo-
cage. Reflex functions were tested by lifting each animalgie und Immunbiologie, Versbacherstr. 7, D-97078 Wu¨rzburg, Germany.
by the tail and placing it on the edge of the cage (grab-Fax: /49-931-2013934. E-mail: Markus.Czub@vax.rz.uni-wuerzburg.-
d400.de. bing reflex) and by short falls (placing reflex). After infec-
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TABLE 1
Infectivity Associated with Various Organs Isolated from Neonatally Inoculated Rats
Virus Seruma Spleenb Thymusb CNSc P-MOb Microgliab
FB29d 4.4 { 0.2 4.2 { 0.2 4.6 { 0.2 3.8 { 0.2 4.1 { 0.2 1
(n  22) (n  17) (n  19) (n  16) (n  12) (n  3)
NT40d 5.0 { 0.2 4.3 { 0.4 4.3 { 0.1 5.7 { 0.2 4.9 { 0.2 0 – 2
(n  10) (n  4) (n  4) (n  4) (n  10) (n  4)
a Serum titers are expressed as log FFU/ml { SE.
b Titers from spleen, thymus, peritoneal cells (P-MO), or microglial cells are expressed as log FFU/106 cells { SE.
c CNS titers are expressed as log FFU/g tissue { SE.
d FB29 or NT40 was administered ip (4 1 104 FFU in 50 ml).
tion with either virus, clinical signs progressed slowly teins (Figs. 1a and 1e – 1g). Positive signals were found
in association with vascular structures as well as withbut the affected animals usually did not die before 100
days, a time when all experiments were terminated. glial cells but not with neurons (Figs. 1a, 1b, and 1d –
1g). Of positive blood vessels, the inner cellular liningHistopathological examination of brain tissues re-
vealed mild (FB29) and extensive (NT40) spongiform de- was stained with antiviral antibodies, indicating infection
of endothelial cells. This result was confirmed by doublegeneration, predominantly of brain-stem areas. The inner
molecular layer (Fig. 1a) and to a lower extent the granu- staining using hyperimmune serum and Griffonia simplic-
ifolia B4 isolectin (Sigma) specific for endothelial cells oflar cell layer (Fig. 1b) of the cerebellum displayed vacuoli-
zation in brains from NT40- but not FB29 (not shown)- blood vessels (Fig. 1e) and for microglia (21 –23) (Fig.
1f). Some cells positive for NT40 also reacted with anti-infected rats. A critical determinant of neuropathogenicity
is the level of CNS infection. Single-cell suspensions ferritin antibodies (Biogenex) indicative of infection of mi-
croglial cells (24) (Figs. 1f and 1g). Of infected glial cells,made from brains of adult rats (5 weeks of age) neona-
tally inoculated with NT40 contained 100-fold more pro- some possessed a highly ramified morphology (Fig. 1h),
suggesting that they were nonactivated microglial cells.ductively infected cells than cell suspensions from the
CNS of FB29-infected rats (P  0.001, two-tailed t test; These results showed that NT40 possessed an ex-
panded cellular tropism within the CNS compared toTable 1) as revealed by means of an infectious center
assay (16). FB29. Infection of vascular elements by NT40 possibly
contributed to both enhanced levels of CNS infectionPrevious studies utilizing various neuropathogenic
MuLVs in rats and mice suggested that infection of brain and facilitation of viral spread into CNS parenchyma.
However, both viruses induced spongiosis, and the ex-vascular elements may play a key role (10, 17– 20) or may
even be sufficient (17) for the induction of neurological tent of spongiform lesions correlated with the level of
glial infection. These cells were identified as microglia.disease. Employing virus-specific immunohistochemistry
using a virus-specific hyperimmune serum (16), as well For further verification, FACS analyses were performed.
Microglia were isolated from adult rat brains by meansas in situ hybridization on brain tissues, we found no
evidence for the presence of either FB29 RNA (16) or of a method previously developed at our institute (25).
We could recover 0.8 – 1.7 1 106 cells from a brain andFB29 proteins (Fig. 1c) in cells associated with blood
vessels. FB29-specific signals obtained independently by spinal cord of an adult rat. The majority of these cells
(55 – 70%) expressed CD11b/c and low-to-moderate lev-both techniques were rare, were scattered predominantly
over brain-stem areas, and were associated with small els of CD45 as revealed by FACS analysis (16) and were
regarded as microglial cells (25). We saw no differencesround cells with scanty cytoplasms and small, polymor-
phic, rather hyperchromatic nuclei. These cells were re- in total cell numbers nor in the quantitative distribution of
the subpopulations when comparing preparations fromgarded as microglia (16).
Analysis of NT40 brains revealed a widespread distri- uninfected, FB29-infected, or NT40-infected rats (data not
shown). For additional antiviral staining, cells were fixedbution of both viral RNA (Figs. 1b and 1d) and viral pro-
FIG. 1. Microscopic examination of infected rat brains. Spongiform changes (arrows) in (a) the molecular layer (antiviral immunostaining brown)
and (b) the granule cell layer, respectively, of a rat cerebellum infected with NT40. (c) Immunohistochemical staining of a single cell (arrow) infected
with FB29. (d) In situ hybridization of a NT40 brain-stem area exhibiting positive signals associated with single cells as well as with a blood vessel.
(e) Double labeling employing GSA (blue) and antiviral staining (brown) indicates NT40 infection of an endothelial cell. (f– h) Dual immunolabeling
showing positive reactions for ferritin (blue) and viral proteins (brown or red) in NT40-infected microglia. Note that not all cells were positive for
both signals. (h) Ramified morphology stained by antiviral antibodies (arrows) indicating NT40 infection of nonactivated microglial cell(s). Original
magnifications: a, c, h, 2501; b, d, 1501; e, f, g, 4801.
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FIG. 2. Cytofluorographic analysis of microglial cells. After density gradient centrifugation, brain cells were stained with monoclonal antibodies
OX42 and OX1 and with virus-specific hyperimmune serum. CD11b/c//CD45low were regarded as microglial cells, gated (as seen in A), and further
analyzed for expression of viral proteins. (B) No antiviral staining could be detected in microglia from uninfected rats, (C) less than 3% of all microglia
expressed viral proteins in FB29 infected animals, and (D) around 12% in NT40-infected rats.
in 3.7% formaldehyde –PBS for 30 min and permeabilized tropism within the CNS were presented. Whereas Kai
and Furuta found viral proteins in glial cells (26), Hoffmanwith 0.3% Triton X-100 (Sigma) for 30 min after cell sur-
face labeling. Employing triple immunostaining, 12% of et al. reported this same virus, PVC 211, to be restricted
to endothelial cells of brain blood vessels (BVEC) asmicroglial cells (CD11b/c//CD45low) isolated from NT40-
infected rats were found to react specifically with antiviral revealed by dual (immuno)labeling using virus-specific
antibodies and RCA-1 (17). However, RCA-1 is specificantibodies (Fig. 2D). This indicated an infection of mi-
croglia with NT40 and confirmed our histological data. for both BVEC and microglial cells (8, 27, 28). Acknowl-
edging all these data including ours, microglial infectionMicroglial cells from FB29-infected rats could also be
stained with antiviral antibodies, yet to a lower degree has to be considered as an inevitable event in MuLV-
induced neurodegeneration of rats. In brains of NT40-(3%) compared to microglia from NT40-infected rats
(Fig. 2C). Among nonmicroglial cells purified with this infected rats, infection of microglia was abundant, both
in degenerated and in healthy brain areas. FB29-infectedtechnique, no specific staining with antiviral antibodies
was observed (data not shown). glia cells were rather rare and more distant from dis-
eased regions. Neurons failed to show viral infection, inIn previous studies on neuropathogenic MuLV in
Fisher rats, apparently conflicting results on the cellular regions both with and without spongiform alterations.
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Altogether, these findings support hypotheses sug-
gesting that the pathogenesis of spongiform change is
indirectly mediated through microglial infection.
However, after seeding microglial cells from NT40- or
FB29-infected diseased rats as infectious centers, only
very few cells were found to produce virus (Table 1).
Similarly, release of infectious virus particles (NT40) into
the supernatants of cultured microglia preparations was
negligible as titers found were below 20 focus-forming
units/ml supernatant (data not shown). Our data demon-
strate that a high proportion of microglia cells was in-
fected with NT40 and a lower proportion with FB29, yet,
under the experimental conditions given here, this infec-
tion was nonproductive.
Although the significance of this finding is not clear, it
is consistent with observations made in related mouse
models of retroviral neurodegeneration (12, 29). It has
been shown that microglial infection with neurovirulent
MuLV resulted in defective processing of viral envelope
protein (29), intracellular budding of virus particles (12,
29), and only limited release of infectious virus into super-
natants of cultivated microglia, yet infected microglia
were highly infectious in vivo (29). These viral– host inter-
FIG. 3. Viremia kinetics of FB29 and NT40. Each symbol represents
actions may represent functional disturbances conse- a titration of an individual animal.
quently leading to disruption of normal brain functions.
To find out whether nonproductive infection was unique
to microglial cells, we analyzed viral– host interactions an enhanced viral spread in peripheral tissues before a
progressively developing, age-dependent restriction ofin another cell type of the monocytic lineage, peritoneal
macrophages. retroviral replication was established. The dynamic inter-
action of the efficiency of viral spread and the develop-For the isolation of peritoneal cells, 10 ml of a 10%
sucrose– PBS solution was administered ip into the peri- ment of age-dependent restriction of retroviral infection
is a key factor that controls the level of CNS infectiontoneal cavity of killed rats. Animals were carefully rotated
to achieve a thorough lavage. About 7 ml of the adminis- (30 – 32). A reliable indicator of the efficiency of replica-
tion and/or viral spread are the kinetics of viremia (33,tered solution was recovered from the abdomen and
spun at 250 g for 10 min at 47. The pelleted cells were 34). A comparison of viremia titers for both viruses, NT40
and FB29, revealed similar kinetics (Fig. 3) and almostsuspended in 3 ml of erythrocyte-lysis buffer (0.155 M
NH4Cl, 0.01 M KHCO3, 0.1 mM EDTA in H2O) for 3 min, identical viremia levels (P  0.02, two-tailed t test; Table
1). Among other peripheral organs, i.e., spleen and thy-washed in PBS, and counted in a Neubauer chamber
before further analyses. Of the peritoneal cells collected mus, no significant (when P  0.02, two-tailed t test)
differences in their respective levels of infection (FB29by lavaging peritoneal cavities of adult rats, 70– 80% ex-
pressed both CD45 and CD11b/c (data not shown) and versus NT40) were found when compared with each
other (Table 1). Therefore, after infection with either NT40were thus regarded as macrophages. When seeded as
infectious centers, peritoneal cells isolated from FB29- or FB29, BVEC as well as peritoneal macrophages and
microglial cells were probably exposed to similar viralinfected rats were found to contain six times less produc-
tively infected cells than those isolated from NT40-in- loads at similar time points. The enhanced tropism of
NT40 for these cells is probably independent of the es-fected rats (P  0.02, two-tailed t test; Table 1). It was
also noted that neither the total numbers of peritoneal tablishment of age-dependent susceptibility to retroviral
infection.cells nor the profile of the cellular compositions ap-
peared to be influenced by infection with either virus (as In summary, our results confirm previous studies by
Kai and Furuta (26) in that a highly neuropathogenicrevealed by FACS analysis, data not shown), indicating
that the infection was nonlytic. Thus, enhanced neuropa- MuLV variant could be generated by serial in vivo pas-
sages. We further demonstrate that enhancement ofthogenicity of NT40 correlated with enhanced tropism
not only for microglial and vascular brain cells but also MuLV-associated neuropathogenicity correlated with an
expanded cellular tropism within the CNS and elevatedfor peritoneal macrophages.
Enhanced numbers of NT40-infected cells of the viral titers in cells of the monocytic lineage, macrophages
and microglia. Nonproductive infection appeared to bemonocytic lineage and of BVEC might have resulted from
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